95.7 TO 52 BIOHEART MYOCELL BEATS MESOBLAST MPCS IN SIDE BY SIDE PHASE II/III CLINICAL TRIAL PERFORMANCE IN THE PRIMARY END POINT MEASURE OF EXERCISE CAPACITY IMPROVEMENT IN HEART FAILURE PATIENTS VIA 6 MIN. WALK TESTING.
95.7 TO 53 BIOHEART MYOCELL BEATS CARDIO3 C-CURE CARDIAC STEM CELLS IN SIDE BY SIDE COMPARISON – 6 MIN. WALK.
95.7 TO 53 BIOHEART MYOCELL BEATS CAPRICOR CARDIAC STEM CELLS IN SIMILAR CLINICAL STUDIES – 6 MIN. WALK.